Not recruiting
Ebola disease
Not recruitingStudy on the Long-Term Immunity of the Ebola Vaccine VSV-EBOV and Booster Dose for Workers at Risk of Ebola Exposure
Registered drugNo placebo
Study on the Long-Term Immunity of the Ebola Vaccine VSV-EBOV and Booster Dose for Workers at Risk of Ebola Exposure
Registered drugNo placebo
- Disease:Ebola disease
- Substances:Recombinant vesicular stomatitis virus - Zaire ebolavirus vaccine (live)
Countries:
Germany
Germany- Participants:18–64 years · Healthy volunteers
- Substances:Recombinant vesicular stomatitis virus - Zaire ebolavirus vaccine (live)